The Society for Immunotherapy of Cancer (SITC) hosted Session 302 during the 38th Annual Meeting & Pre-Conference Programs on Sunday, November 5, 2023. Available here are the presentation slides and video from “Session 302: Thomas Waldmann Memorial Plenary Session: Cell-based Immunotherapies for Treatment of Cancer” as permitted by presenters.
Christine Brown, PhD – City of Hope
Chris Klebanoff, MD – Memorial Sloan Kettering Cancer Institute
Cell-based immunotherapies have entered the standard of care for B-lymphoid malignancies and are now showing encouraging signs of efficacy across a diverse range of adult and pediatric solid cancers. To make further progress, the field now must address three critical questions: 1) the identification and therapeutic targeting of clonally conserved cancer-specific antigens, 2) the phenotypic and functional attributes of effective versus ineffective cell products, and 3) the molecular mechanisms leading to lymphocyte dysfunction within tumors and translatable strategies to overcome these barriers. In this session, speakers will describe innovative new strategies and emerging clinical data focused on achieving these goals using CARs, TCRs, and TIL.
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Sunday, November 502:14:02